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Cell cycle: Will the real Cdk-activating kinase please stand up
Giulio F. Draetta
Activation of a cyclin-dependent kinase (Cdk) requires
its association with a cyclin subunit and phosphorylation
on a conserved residue by the Cdk-activating kinase
(CAK). The discovery in budding yeast of a novel CAK
that is structurally distinct from the CAKs of other
eukaryotes raises questions about the ‘true’ CAK.
Address: Department of Experimental Oncology, European Institute of
Oncology, 435 Via Ripamonti, 20141 Milan, Italy.
E-mail: gdraetta@ieo.cilea.it
Electronic identifier: 0960-9822-007-R0050
Current Biology 1997, 7:R50–R52
© Current Biology Ltd ISSN 0960-9822
Phosphorylation of a conserved threonine residue within
the ‘T-loop’ of each cyclin-dependent kinase (Cdk) [1,2]
is required for proper activation of the kinase, and hence
for passage through the cell-cycle phase it regulates.
Although threonine phosphorylation does not play a direct
role in catalysis, it appears to stabilize the overall structure
of the Cdk–cyclin complex (see [3,4] for reviews). The rel-
evant threonine residue is located within the conserved
domain VIII that occurs in all members of the protein
kinase superfamily, and phosphorylation of the equivalent
residue in other protein serine/threonine or tyrosine
kinases appears to be important for their biological func-
tion (see [3] for review). In studies of Cdc2, the major Cdk
of the fission yeast Schizosaccharomyces pombe, Booher and
Beach [5] identified Thr167 as a potential phosphorylation
site, because the sequence surrounding an analogous
serine, threonine or tyrosine is shared by other protein
kinases. On mutation of Thr167, Cdc2 was rendered
biologically inactive; furthermore, both human and
Xenopus Cdc2 homologues are phosphorylated at equiva-
lent sites, and this phosphorylation is required for their
kinase activity [6–8].
Various experimental approaches demonstrated the
existence of a Cdk-activating kinase (CAK) [7,8] which
phosphorylates the conserved threonine of Cdks. Using
Cdk activation as an assay, three groups purified and
characterized a CAK protein complex, one subunit of which
was found to be the MO15 protein, a Cdk-like kinase that
had previously been identified in Xenopus [9–11]. Depletion
of MO15 — now called Cdk7 — from cytoplasmic extracts
of Xenopus eggs or embryos resulted in elimination of CAK
activity, suggesting that MO15-containing complexes are
indeed the major source of CAK activity in these cells.
Cdk7 is itself regulated through association with a cyclin-
like regulatory subunit and by phosphorylation. A cyclin,
called cyclin H, has been identified as binding to Cdk7
[12,13], and the Cdk7–cyclin H holoenzyme can phospho-
rylate complexes containing Cdc2, Cdk2 and Cdk4, as well
as monomeric recombinant Cdk2. 
Cdk7–cyclin H complexes contain an additional subunit,
MAT1, which stabilizes the complex. This effect of
MAT1 is independent of phosphorylation of a threonine
residue in Cdk7 [14], which by itself can favour assembly
of the  Cdk7–cyclin H complex in a MAT1-independent
manner [15]. Cdk7 is expressed at constant levels through-
out the cell cycle, and in both normal and transformed
cells it is localized to the nucleus; it is detected also in
quiescent cells [16] This is in keeping with previous
observations which indicated that measurable CAK activ-
ity does not vary between quiescent and proliferating cells
nor through the cell cycle, suggesting that CAK activity is
not a limiting factor in controlling Cdks in response to
growth factors and intracellular signals. The Cdk7–cyclin
H complex also constitutes one component of the tran-
scription factor complex TFIIH, which is required for
both RNA polymerase II-dependent transcription and
nucleotide-excision repair of DNA [17]. In addition to
Cdks, Cdk7–cyclin H phosphorylates the carboxy-termi-
nal domain (CTD) of RNA polymerase II. This raises the
interesting possibility that Cdk7–cyclin H contributes to
the integration of multiple signaling pathways. 
In a lower eukaryote, the fission yeast S. pombe, Mop1
(also called Crk1) [18,19] is a good candidate for CAK.
Yeast cells lacking the mop1(crk1) gene fail to divide and
show a heterogeneous phenotype, with some cells having
condensed chromosomes and multiple septa. Expression
of human Cdk7 in mop1-deleted cells rescues this defect.
As is the case for the Cdk7–cyclin H complex,
Mop1(Crk1), in a complex with the Mcs2 cyclin subunit,
is able to phosphorylate both a Cdk2 fusion protein and a
CTD peptide in vitro — although there is no evidence at
present that Mop1 is required for RNA polymerase II-
dependent transcription or that it phosphorylates the
CTD in vivo. Although it is not known whether the
Mop1–Mcs2 complex is the sole, or even a predominant,
CAK in S. pombe, its ability to phosphorylate and activate
Cdks, along with the genetic interactions of the Mop1
and Mcs2 genes with mitotic regulatory genes, make this
complex a good candidate for a true CAK. In fact, mcs2
mutations are able to suppress the ‘mitotic catastrophe’
phenotype in S. pombe that involves dysregulation of
DNA replication, mitosis and cytokinesis [20,21].
Furthermore, mop1 is allelic to another mitotic-catastro-
phe suppressor gene, mcs6 [18].
In the budding yeast, Saccharomyces cerevisiae, the Kin28
protein kinase was until recently believed to be a likely
candidate for CAK, given its close similarity to Cdks, 47 %
amino-acid identity with vertebrate Cdk7, and association
with a cyclin-like subunit, Ccl1. But although Kin28 is a
component of yeast TFIIH, it does not appear to
phosphorylate the S. cerevisiae Cdc28 protein (Cdc28 is the
key S. cerevisiae Cdk, a homologue of Cdc2). Furthermore,
although kin28 and ccl1 mutant strains show defects in CTD
phosphorylation and the transcription of genes by RNA
polymerase II, threonine phosphorylation of Cdc28 is unaf-
fected in a kin28ts mutant strain, and immunodepletion of
Kin28 from yeast cell extracts leaves the CAK activity
unmodified.
Over the past few months, three papers have appeared that
describe the identification of a novel protein that has  CAK
activity in S. cerevisiae [22–24]. These studies used bio-
chemical fractionation to purify a budding yeast CAK, and
all ended up purifying and identifying the same protein,
which has been called Cak1 or Civ1. Cak1 is only distantly
related to other protein kinases, its closest relative being
budding yeast Cdc28. Interestingly, the protein lacks the
canonical consensus Gly–x–Gly–x–x–Gly (where x is any
amino acid) that is present in the ATP-binding loop of most
protein kinases; in Cak1 this is replaced by the sequence
Asp–Ile–Thr–His–Cys–Gln. Recombinant yeast or bacterial
Cak1 can be produced as a single purified protein of 45 kDa
that is able to phosphorylate both monomeric and cyclin-
bound forms of Cdc28 and Cdk2 in vitro, indicating that it
can function in the absence of post-translational modifica-
tions or a regulatory subunit. Cak1 copurifies with Cdc28 in
yeast cell extracts, and its depletion with antibodies com-
pletely removes CAK activity, demonstrating that the Cak1
protein constitutes a major (if not the sole) S. cerevisiae
CAK. Cak1 overexpression increases the detectable CAK
activity in yeast extracts, and, in addition, Cdc28 kinase
activity and Cdc28 phosphorylation are severely reduced in
Cak1-mutant cells. But Cak1 does not have CTD-kinase
activity, and it is probably not a subunit of TFIIH (see
Table 1): in contrast to Cdk7–cyclin H, Cak1 does not elute
in large macromolecular complexes.
Cak1 is essential for the viability of budding yeast cells. In
cells carrying a temperature-sensitive mutation or deletion
of the Cak1 gene, Cdc28 phosphorylation is severely
reduced and the cells arrest largely in G1 phase of the cell
cycle (70 %), with the remainder of cells in G2 (30 %) [24].
A distinct Cak1 mutation isolated by others showed a pre-
dominant G2 arrest [23]; this difference might be caused by
defects in the mutant Cak proteins which preferentially
affect the interaction with one or other Cdk. A genetic
interaction between the Cak1 mutation and deletion of the
mitotic cyclin gene Clb2 has also been found. Cells carrying
both defects grow very poorly compared to cells carrying
either defect alone, suggesting that the Cak1 mutant
protein is defective in recognizing Clb2 kinase complexes
as substrate.
In summary, although Cak1 is structurally most closely
related to the Cdk family of protein kinases, it has the
unique feature of being functional as a monomer, and it
lacks a glycine-rich loop. Interestingly, as is the case for the
phosphorylation of Cdk2 by Cdk7, Cak1 can phosphorylate
monomeric Cdc28, and phosphorylated Cdc28 can be
activated by the addition of cyclin, suggesting that there is
not an absolute need for cyclin binding prior to Cdk
phosphorylation. Because it has also been demonstrated
that a Cdk–cyclin complex can be active in the absence of
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Table 1
Two distinct protein kinases regulate activation of Cdks and
basal transcription in S. cerevisiae. 
Organism TFIIH/CTD phosphorylation Cdk-activating kinase
Vertebrates Cdk7–cyclin H Cdk7–cyclin H
S. pombe Mop1(Crk1)–Mcs2 Mop1(Crk1)–Mcs2
S. cerevisiae Kin28–Ccl1 Cak1(Civ1)
Figure 1
Activation of a cyclin-dependent kinase (Cdk) requires association with
a cyclin subunit and phosphorylation by a Cdk-activating kinase (CAK).
Evidence from different model systems indicates that phosphorylation
can proceed independently of complex assembly, and conversely that
complex assembly can occur either before or after phosphorylation. In
either case, the fully active kinase is represented by the cyclin-bound
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phosphorylation (even though it may have only 1 % of the
activity of the phosphorylated complex) one can hypothe-
size that cyclin binding and threonine phosphorylation
could be truly independent events (Fig. 1). So far, though,
there is no evidence for a monomeric threonine-phosph-
orylated Cdk being active. Clearly, cyclin binding and
threonine phosphorylation of the Cdk are not required for
catalysis, but rather for structural stabilization of the
enzyme, as is also indicated by studies on the three-
dimensional structure of a Cdk–cyclin complex [1,2].
The identification of Cak1, a protein kinase of S. cerevisiae
that is able to phosphorylate and activate Cdc28 but unable
to phosphorylate the CTD of RNA polymerase II, raises
the interesting possibility that a similarly more specific
CAK exists in higher eukaryotes as well. In contrast to
higher eukaryotes, S. cerevisiae appears to have two distinct
enzymes to regulate TFIIH and Cdk activation. Although
there may be a truly different system in S. cerevisiae com-
pared to other eukaryotes, it is worth keeping in mind the
‘circumstantial evidence’ that supports the possible exis-
tence of a Cak1 homologue in other organisms: first, the
‘strange’ substrate specificity of Cdk7–cyclin H, which
divides itself between TFIIH and Cdks; second, the fact
that it has not been genetically demonstrated that the com-
plexes identified in S. pombe or higher eukaryotes are the
exclusive CAKs in these organisms; and third, the ongoing
debate about whether these activities have monomeric or
cyclin-complexed Cdks as substrates, and how this relates
to Cdk assembly. As was the case for Cak1 in S. cerevisiae, a
CAK activity in extracts from chicken cells was found to co-
purify with Cdc2 [7], suggesting that a Cak1-like kinase
might indeed exist in these cells. Most of us working on
cell-cycle regulation still cannot explain why such an impor-
tant step in Cdk activation does not appear to be tightly
regulated in response to mitogenic signaling. We like to
believe, therefore, that a ‘true’ homologue of S. cerevisiae
Cak1 could provide the regulated CAK activity in higher
eukaryotic cells.
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